Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)

@article{Tosetto2012PredictingDR,
  title={Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)},
  author={A. Tosetto and A. Iorio and M. Marcucci and T. Baglin and M. Cushman and S. Eichinger and G. Palareti and D. Poli and R. C. Tait and J. Douketis},
  journal={Journal of Thrombosis and Haemostasis},
  year={2012},
  volume={10}
}
  • A. Tosetto, A. Iorio, +7 authors J. Douketis
  • Published 2012
  • Medicine
  • Journal of Thrombosis and Haemostasis
    • Summary.  Background:  In patients with unprovoked venous thromboembolism (VTE), the optimal duration of anticoagulation is anchored on estimating the risk of disease recurrence. 
    View on Wiley
    onlinelibrary.wiley.com
    324 Citations
    Highly Influential Citations
    9
    Background Citations
    52
    Methods Citations
    21
    Results Citations
    1

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

    324 Citations
    Citation Type

    Citation Type

    Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data
    • 52
    • PDF
    D‐dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry
    Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
    • 3
    Diagnostic, Prognostic, and Therapeutic Challenges in Venous Thromboembolism
    Retrospective evaluation of venous thromboembolism: Are all transient provoking events the same?
    • 7
    d‐dimer is a predictor of clot resolution in patients with pulmonary thromboembolism: A retrospective cohort study
    • 1
    D‐dimer at venous thrombosis diagnosis is associated with risk of recurrence
    • 11
    Venous thromboembolism: risk of recurrence and long-term anticoagulation.
    • 1
    Prevention and treatment of venous thromboembolic disease
    • PDF
    Biomarkers for the prediction of venous thromboembolism in the community.
    • 9

    References

    SHOWING 1-10 OF 35 REFERENCES
    Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model
    • 405
    Unprovoked recurrent venous thrombosis: prediction by D‐dimer and clinical risk factors
    • 49
    Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
    • 469
    • PDF
    Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
    • 236
    • PDF
    Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting
    • 83
    The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    • 657
    • PDF
    D-dimer levels and risk of recurrent venous thromboembolism.
    • 313
    • PDF
    Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.
    • 265
    • PDF
    Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study.
    • 131
    • PDF
    Predictive Value of D‐Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia
    • 250
    • PDF